Prognostic Usefulness of Maximum Standardized Uptake Value on FDG-PET in Surgically Resected Non-small-cell Lung Cancer |
Nguyen Xuan Canh
(Department of Nuclear Medicine, Seoul National University College of Medicine)
Lee Won-Woo (Department of Nuclear Medicine, Seoul National University College of Medicine) Sung Sook-Whan (Department of Thoracic Surgery, Seoul National University College of Medicine) Jheon Sang-Hoon (Department of Thoracic Surgery, Seoul National University College of Medicine) Kim Yu-Kyeong (Department of Nuclear Medicine, Seoul National University College of Medicine) Lee Dong-Soo (Department of Nuclear Medicine, Seoul National University College of Medicine) Chung June-Key (Department of Nuclear Medicine, Seoul National University College of Medicine) Lee Myung-Chul (Department of Nuclear Medicine, Seoul National University College of Medicine) Kim Sang-Eun (Department of Nuclear Medicine, Seoul National University College of Medicine) |
1 | Higashi K, Ueda Y, Arisaka Y, Sakuma T, Nambu Y, Oguchi M, et al. F-18 FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer. J Nucl Med 2002;43:39-45 |
2 | Vesselle H, Schmidt RA, Pugsley JM, Li M, Kohlmyer SG, Vallires E, et al. Lung cancer proliferation correlates with F-18 fluorodeoxyglucose uptake by positron emission tomography. Clin Cancer Res 2000;6:3837-44 |
3 | Shankar LK, Sullivan DC. Functional imaging in lung cancer. J Clin Oncol 2005;23:3203-11 DOI ScienceOn |
4 | Vansteenkiste JF, Stroobants SG, Dupont PJ, De Leyn PR, Verbeken EK, Deneffe GJ, et al. Prognostic importance of the standardized uptake value on F-18 fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. Leuven Lung Cancer Group. J Clin Oncol 1999;17:3201-6 DOI |
5 | Caraco C, Aloj L, Chen LY, Chou JY, Eckelman WC. Cellular release of F-18 2-fluoro-2-deoxyglucose as a function of the glucose-6-phosphatase enzyme system. J Biol Chem 2000;275:1 8489-94 |
6 | Higashi K, Clavo AC, Wahl RL. Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. J Nucl Med 1993;34:414-9 |
7 | Aloj L, Caraco C, Jagoda E, Eckelman WC, Neumann RD. Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture. Cancer Res 1999;59:4709-14 |
8 | Mamede M, Higashi T, Kitaichi M, Ishizu K, Ishimori T, Nakamoto Y, et al. F-18 FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung. Neoplasia 2005;7:369-79 DOI |
9 | Downey RJ, Akhurst T, Gonen M, Vincent A, Bains MS, Larson S, et al. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol 2004;22:3255-60 DOI ScienceOn |
10 | Tateishi U, Nishihara H, Tsukamoto E, Morikawa T, Tamaki N, Miyasaka K. Lung tumors evaluated with FDG-PET and dynamic CT: the relationship between vascular density and glucose metabolism. J Comput Assist Tomogr 2002;26:185-90 DOI ScienceOn |
11 | Duhaylongsod FG, Lowe VJ, Patz EF, Jr., Vaughn AL, Coleman RE, Wolfe WG. Lung tumor growth correlates with glucose metabolism measured by F-18 fluorodeoxyglucose positron emission tomography. Ann Thorac Surg 1995;60:1348-52 DOI ScienceOn |
12 | Higashi K, Ueda Y, Sakurai A, Wang XM, Xu L, Murakami M, et al. Correlation of Glut-1 glucose transporter expression with. Eur J Nucl Med 2000;27:1778-85 DOI ScienceOn |
13 | Sasaki R, Komaki R, Macapinlac H, Erasmus J, Allen P, Forster K, et al. F-18 fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer. J Clin Oncol 2005;23:1136-43 DOI ScienceOn |
14 | www.intmed.mcw.edu/clincalc/body.html |
15 | Cerfolio RJ, Bryant AS, Ohja B, Bartolucci AA. The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. J Thorac Cardiovasc Surg 2005;130:151-9 DOI ScienceOn |
16 | Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer. Ann Thorac Surg 1996;61: 1470-6 DOI ScienceOn |
17 | Chung JK, Lee YJ, Kim SK, Jeong JM, Lee DS, Lee MC. Comparison of F-18 fluorodeoxyglucose uptake with glucose transporter-1 expression and proliferation rate in human glioma and non-small-cell lung cancer. Nucl Med Commun 2004;25:11-7 DOI ScienceOn |
18 | AJCC Cancer Staging Manual. 6th ed. NY: Sringer; 2002. p. 167-177 |
19 | Jeong HJ, Min JJ, Park JM, Chung JK, Kim BT, Jeong JM, et al. Determination of the prognostic value of F-18 fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer. Nucl Med Commun 2002;23:865-70 DOI ScienceOn |
20 | Eschmann SM, Friedel G, Paulsen F, Reimold M, Hehr T, Budach W, et al. Is standardised F-18 FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer? Eur J Nucl Med Mol Imaging 2006;33:263-9 DOI |